74 related articles for article (PubMed ID: 26071582)
1. Alternative splicing of placental lactogen (CSH2) in somatotroph pituitary adenomas.
Lekva T; Berg JP; Lyle R; Heck A; Bollerslev J; Ueland T
Neuro Endocrinol Lett; 2015; 36(2):136-42. PubMed ID: 26071582
[TBL] [Abstract][Full Text] [Related]
2. Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
Lekva T; Berg JP; Lyle R; Heck A; Ringstad G; Olstad OK; Michelsen AE; Casar-Borota O; Bollerslev J; Ueland T
Endocrinology; 2013 Sep; 154(9):3331-43. PubMed ID: 23825128
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly.
Lekva T; Berg JP; Fougner SL; Olstad OK; Ueland T; Bollerslev J
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1506-14. PubMed ID: 22585092
[TBL] [Abstract][Full Text] [Related]
4. Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery.
Lekva T; Berg JP; Heck A; Lyngvi Fougner S; Olstad OK; Ringstad G; Bollerslev J; Ueland T
PLoS One; 2013; 8(6):e66927. PubMed ID: 23825587
[TBL] [Abstract][Full Text] [Related]
5. Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns.
Männik J; Vaas P; Rull K; Teesalu P; Rebane T; Laan M
J Clin Endocrinol Metab; 2010 May; 95(5):2433-42. PubMed ID: 20233782
[TBL] [Abstract][Full Text] [Related]
6. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response.
Fougner SL; Lekva T; Borota OC; Hald JK; Bollerslev J; Berg JP
J Clin Endocrinol Metab; 2010 May; 95(5):2334-42. PubMed ID: 20335450
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
10. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.
Yamato A; Nagano H; Gao Y; Matsuda T; Hashimoto N; Nakayama A; Yamagata K; Yokoyama M; Gong Y; Shi X; Zhahara SN; Kono T; Taki Y; Furuki N; Nishimura M; Horiguchi K; Iwadate Y; Fukuyo M; Rahmutulla B; Kaneda A; Hasegawa Y; Kawashima Y; Ohara O; Ishikawa T; Kawakami E; Nakamura Y; Inoshita N; Yamada S; Fukuhara N; Nishioka H; Tanaka T
Commun Biol; 2022 Nov; 5(1):1304. PubMed ID: 36435867
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas.
Tang Y; Xie T; Wu S; Yang Q; Liu T; Li C; Liu S; Shao Z; Zhang X
Endocrine; 2021 Nov; 74(2):375-386. PubMed ID: 34043183
[TBL] [Abstract][Full Text] [Related]
13. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
14. Differential placental expression profile of human Growth Hormone/Chorionic Somatomammotropin genes in pregnancies with pre-eclampsia and gestational diabetes mellitus.
Männik J; Vaas P; Rull K; Teesalu P; Laan M
Mol Cell Endocrinol; 2012 May; 355(1):180-7. PubMed ID: 22387044
[TBL] [Abstract][Full Text] [Related]
15. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
16. Genetic abnormalities of somatostatin receptors in pituitary tumors.
Lania A; Mantovani G; Spada A
Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.
Heck A; Emblem KE; Casar-Borota O; Bollerslev J; Ringstad G
Endocrine; 2016 May; 52(2):333-43. PubMed ID: 26475495
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary.
Yamada S; Sano T; Stefaneanu L; Kovacs K; Aiba T; Sawano S; Shishiba Y
J Clin Endocrinol Metab; 1993 Feb; 76(2):352-6. PubMed ID: 8432778
[TBL] [Abstract][Full Text] [Related]
19. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
[TBL] [Abstract][Full Text] [Related]
20. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly.
Fougner SL; Casar-Borota O; Heck A; Berg JP; Bollerslev J
Clin Endocrinol (Oxf); 2012 Jan; 76(1):96-102. PubMed ID: 21722151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
